News

Filter

Current filters:

North AmericaAxiron

Actavis confirms challenge of Lilly’s Axiron patent

Actavis confirms challenge of Lilly’s Axiron patent

14-11-2013

US generics major Actavis confirms that it has filed an Abbreviated New Drug Application with the US…

ActavisAxironEli LillyGenericsLegalMen's HealthNorth AmericaPatentsRegulation

Eli Lilly exceeds expectations with third quarter results

Eli Lilly exceeds expectations with third quarter results

24-10-2013

US pharma major Eli Lilly has announced financial results for the third quarter of 2013. Despite the…

AlimtaAmyvidAxironCialisCymbaltaEffientEli LillyEvistaFinancialForteoHumalogNorth AmericaPharmaceuticalStratteraTrajentaZyprexa

US FDA approves Axiron, first testosterone replacement from Eli Lilly and Acrux

25-11-2010

US drug major Eli Lilly (NYSE: LLY) and Australian partner Acrux (ASX: ACR) have received US Food and…

AcruxAxironEli LillyNorth AmericaPharmaceuticalRegulationReproductive

COMPANY SPOTLIGHT

Menarini

Back to top